Trial Profile
A retrospective study to evaluate the efficacy of erlotinib and chemotherapy in patients with pretreated advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Antineoplastics (Primary) ; Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Jun 2016 New trial record